Abstract:Epilepsy Currents, Ahead of Print. Epilepsy-Associated SCN2A (NaV1.2) Variants Exhibit Diverse and Complex Functional Properties Thompson CH, Potet F, Abramova TV, DeKeyser JM, Ghabra NF, Vanoye CG, Millichap JJ, George AL. J Gen Physiol. 2023;155(10):e202313375. doi:10.1085/jgp.202313375. PMID: 37578743; PMCID: PMC10424433Pathogenic variants in neuronal voltage-gated sodium (NaV) channel genes including SCN2A, which encodes NaV1.2, are frequently discovered in neurodevelopmental disorders with and without epilepsy. SCN2A is also a high confidence risk gene for autism spectrum disorder (ASD) and nonsyndromic intellectual disability (ID). Previous work to determine the functional consequences of SCN2A variants yielded a paradigm in which predominantly gain-of-function (GoF) variants cause epilepsy whereas loss-of-function (LoF) variants are associated with ASD and ID. However, this framework is based on a limited number of functional studies conducted under heterogenous experimental conditions whereas most disease-associated SCN2A variants have not been functionally annotated. We determined the functional properties of more than 30 SCN2A variants using automated patch clamp recording to assess the analytical validity of this approach and to examine whether a binary classification of variant dysfunction is evident in a larger cohort studied under uniform conditions. We studied 28 disease-associated variants and 4 common population variants using two distinct alternatively spliced forms of NaV1.2 that were heterologously expressed in HEK293 T cells. Multiple biophysical parameters were assessed on 5,858 individual cells. We found that automated patch clamp recording provided a valid high throughput method to ascertain detailed functional properties of NaV1.2 variants with concordant findings for a subset of variants that were previously studied using manual patch clamp. Additionally, many epilepsy-associated variants in our study exhibited complex patterns of gain- and loss-of-function properties that are difficult to classify overall by a simple binary scheme. The higher throughput achievable with automated patch clamp enables study of a larger number of variants, greater standardization of recording conditions, freedom from operator bias, and enhanced experimental rigor valuable for accurate assessment of NaV channel variant dysfunction. Together, this approach will enhance our ability to discern relationships between variant channel dysfunction and neurodevelopmental disorders.

Roles of KCNA2 in Neurological Diseases: from Physiology to Pathology

Two epilepsy-associated variants in KCNA2 (KV 1.2) at position H310 oppositely affect channel functional expression

KCa2.2 (KCNN2): A physiologically and therapeutically important potassium channel

Neurocardiac pathologies associated with potassium channelopathies

A Novel KCNA2 Variant in a Patient with Non-Progressive Congenital Ataxia and Epilepsy: Functional Characterization and Sensitivity to 4-Aminopyridine

Investigation of novel de novo KCNC2 variants causing severe developmental and early-onset epileptic encephalopathy

A novel autism-associated KCNB1 mutation dramatically slows Kv2.1 potassium channel activation, deactivation and inactivation

KCNT2-Related Disorders: Phenotypes, Functional, and Pharmacological Properties

Voltage-gated potassium channels and genetic epilepsy

Epilepsy-associated SCN2A (NaV1.2) variants exhibit diverse and complex functional properties

A structurally precise mechanism links an epilepsy-associated KCNC2 potassium channel mutation to interneuron dysfunction

Novel KCNQ2 Missense Variant Expands the Genotype Spectrum of DEE7.

Epilepsies associated with KCNQ2 : A spectrum of disorders

Plural molecular and cellular mechanisms of pore domain KCNQ2 encephalopathy

The Multifunctional Role of KCNE2: From Cardiac Arrhythmia to Multisystem Disorders

Development of KCC2 therapeutics to treat neurological disorders

Clinical Study of 30 Novel KCNQ2 Variants/Deletions in KCNQ2-Related Disorders.

Potassium channels and epilepsy

Both Gain- and Loss-of-function Variants of KCNA1 Are Associated with Paroxysmal Kinesigenic Dyskinesia.

No Pain, No Gain of Function: Epilepsy-Associated Variants in SCN2A Defy Classification

Correlation Analyses of Clinical Manifestations and Variant Effects in KCNB1-Related Neurodevelopmental Disorder